Imaging of hormonal characteristics of ovarian cancer by means of positron emission tomography.
- Conditions
- epithelial ovarian cancerTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Registration Number
- EUCTR2011-001429-25-NL
- Lead Sponsor
- niversity Medical Center Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- Not specified
1.Histological evidence or high clinical suspicion with proven malignant ascites and high probability of epithelial ovarian cancer
2.The presence of at least one measurable lesion (RECIST v1.1).
3.Histology or cytology can be obtained (may be ascites)
4.ECOG performance status 0-2.
5.Postmenopausal status (defined as either >45 years with amenorrhea >12 months, or prior bilateral ovariectomy)
6.No history of other ER-positive malignancies
7.Signed written informed consent
8.Able to comply with the protocol
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 16
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 16
1.Use of estrogen receptor ligands, including tamoxifen, fulvestrant or estrogens, during the 5 weeks before entry into the study
2.Life-expectancy = 3 months
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method